A5058661207- Cholangiocarcinoma and Gallbladder Cancer Studies
- MicroRNA in disease regulation
- Cancer Cells and Metastasis
- Cancer Genomics and Diagnostics
- Renal and related cancers
- Plant and soil sciences
- bioluminescence and chemiluminescence research
- Phytoplasmas and Hemiptera pathogens
- 3D Printing in Biomedical Research
- Advanced Chemical Sensor Technologies
- Berry genetics and cultivation research
- Olfactory and Sensory Function Studies
- Air Quality and Health Impacts
- RNA modifications and cancer
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
- Academic and Historical Perspectives in Psychology
- Cancer Mechanisms and Therapy
- Infection Control and Ventilation
- Long-Term Effects of COVID-19
- Burn Injury Management and Outcomes
- Inhalation and Respiratory Drug Delivery
- Pharmacological Effects of Natural Compounds
- Educational and Social Studies
University of Glasgow
2020-2023
University of Naples Federico II
2019
University of Rochester
1980-1982
Objective Cytotoxic agents are the cornerstone of treatment for patients with advanced intrahepatic cholangiocarcinoma (iCCA), despite heterogeneous benefit. We hypothesised that pretreatment molecular profiles diagnostic biopsies can predict patient benefit from chemotherapy and define bases innate chemoresistance. Design identified a cohort iCCA comparable baseline characteristics who diverged as extreme outliers on (survival <6 m in rapid progressors, RP; survival >23 long...
Journal Article PULMONARY RETENTION OF COAL DUSTS Get access P. E. MORROW, MORROW Department of Radiation Biology and Biophysics, University Rochester School Medicine DentistryRochester, NY 14642, U.S.A. Search for other works by this author on: Oxford Academic PubMed Google Scholar F. R. GIBB, GIBB H. BEITER, BEITER AMATO, AMATO C. YUILE, YUILE W. KILPPER The Annals Occupational Hygiene, Volume 26, Issue 2, 1982, Pages 291–307, https://doi.org/10.1093/annhyg/26.2.291 Published: 01 February 1982
It is estimated that 80% of SARS-CoV-2 patients have olfactory disturbances and many also dysgeusia or ageusia (an interruption loss taste, respectively) changes in chemesthesis, the ability to perceive irritants by TRP receptors. Anosmia (loss sense smell) been termed 'sentinel symptoms'. represent a real health risk can cause nutritional deficits'. Infection with oral cavity could production quality saliva, contributing symptoms taste loss. Since the activation TRPs Reactive Oxygen...
It is estimated that 80% of SARS-CoV-2 patients have olfactory disturbances and many also have dysgeusia or ageusia (an interruption loss taste, respectively) changes in chemesthesis, the ability to perceive irritants. Anosmia (loss sense smell) been reported as symptoms seem a particular tendency precede the onset respiratory symptoms.